Anika Therapeutics Inc
SWB:AKP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Anika Therapeutics Inc (AKP) under the Base Case is 19.39 EUR per share.
Compared with the current market price of 11.8 EUR, the stock appears
Undervalued by 39% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Anika Therapeutics Does
Anika Therapeutics makes medical products that help doctors treat joint pain and support healing in bones and soft tissue. Its best-known products are based on hyaluronic acid, a substance used in joint injections and surgical care, and it also sells orthopedic and tissue-healing products used in procedures such as knee, hip, and sports-medicine treatment.
- Headquarters
- United States of America US
- Employees
- 235
- IPO date
- May 16, 1985
Continue AKP Research
Decided on Anika Therapeutics? Get an email when AKP reaches the price you’d buy at. Free with an account.
Other Anika Therapeutics listings
What is the Intrinsic Value of one AKP stock?
The intrinsic value for
Anika Therapeutics Inc (AKP) under the Base Case is 19.39 EUR.
Is AKP stock undervalued or overvalued?
Compared with the current market price of 11.8 EUR, the stock appears Undervalued by 39% .